Elf5 expression is greatly increased when MCF-7 breast cancer cells acquire Tamoxifen or Faslodex resistance by long-term exposure to these anti-estrogens, and these cells also become dependent on Elf5 for their proliferation, suggesting that Elf5 is a key determinant for anti-estrogen resistance [86]. This evidence concerns the gene ELF5 and breast carcinoma.